PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”…
Bravo Flowdex: How This Innovative Platform is Redefining AI Trading Read Bravo Flowdex Spain Report!
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction –…
Net Rowdex: Why Net Rowdex 2025 Emerges as a Next-Gen AI Trading Platform for Investors Read France Report!
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to…
Immediate Edge: Exploring the AI Technology Behind Immediate Edge Trading Platform Germany Insights!
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
Multiple Myeloma Research Foundation (MMRF) Announces New Data from Flagship Research Initiatives at the 22nd International Myeloma Society Annual Meeting
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma…
MBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22
September 19, 2025 16:18 ET | Source: MBX Biosciences, Inc. CARMEL, Ind.,…
CEA Industries Board Authorizes $250 Million Stock Buyback Program
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq:…
RedCloud to Present AI-Native Vision to Digitize and Transform Global Trade
LONDON, Sept. 19, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT)…
ProPlaintiff.ai Launches Agentic AI Platform for Personal Injury Attorneys
Phoenix, Arizona, Sept. 19, 2025 (GLOBE NEWSWIRE) -- ProPlaintiff.ai, the leading AI…
